Increased frequency of gastrin-releasing peptide receptor gene mutations during colon-adenocarcinoma progression

Molecular Carcinogenesis

Volumn 37, Issue 1, 2003, Pages 5-15

  Glover, Sarah C ^a   Tretiakova, Maria S ^a   Carroll, Robert E ^a   Benya, Richard V ^a,b  

^a JESSE BROWN VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN RELEASING PEPTIDE RECEPTOR; MESSENGER RNA; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CHROMOSOME MICRODISSECTION; COLON ADENOCARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; EPITHELIUM CELL; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENETIC CONSERVATION; HUMAN; HUMAN TISSUE; LASER MICROSCOPY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; RECEPTOR GENE; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CHO CELLS; COLONIC NEOPLASMS; CRICETINAE; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; HUMANS; MUTATION; NEOPLASM STAGING; PHENOTYPE; RECEPTORS, BOMBESIN; TRANSFECTION;

EID: 0038414766     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.10117     Document Type: Article

References (45)

1. Tache Y, Mechiorri P, Negri L. Bombesin-like peptides in health and disease. Ann NY Acad Sci 1988;547:1-541.
2. Corgay MH, Dobrzanski DJ, Way JM, et al. Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. J Biol Chem 1991;266:18771-18779.
3. Preston SR, Woodhouse LF, Jones-Blackett S, Miller GV, Primrose JN. High-affinity binding sites for gastrin-releasing peptide on human colorectal cancer tissue but not uninvolved mucosa. Br J Cancer 1995;71:1087-1089.
4. Ferris HA, Carroll RE, Lorimer DL, Benya RV. Location and characterization of the human GRP receptor expressed by gastrointestinal epithelial cells. Peptides 1997;18:663-672.
5. Carroll RE, Matkowskyj KA, Chakrabarti S, McDonald TJ, Benya RV. Aberrant expression of gastrin-releasing peptide and its receptor by well differentiated colon cancers in humans. Am J Physiol 1999;276:G655-G665.
6. Jass JR, Atkin WS, Cuzick J, et al. The grading of rectal cancer: Historical perspectives and a multivariate analysis of 447 cases. Histopathology 1986;10:437-459.
7. Shepherd NA, Saraga E-P, Love SB, Jass JR. Prognostic factors in colonic cancer. Histopathology 1989;14:613-620.
8. Steinberg SM, Barwick KW, Stablein DM. Importance of tumor pathology and morphology in patients with surgically resected colon cancer. Cancer 1986;58:1340-1345.
9. Radulovic S, Miller G, Schally AV. Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). Cancer Res 1991;51:6006-6009.
10. Frucht H, Gazdar A, Jensen RT. Human colon cancer cell line NCI-H716 expresses functional bombesin receptors. Proc Am Assoc Cancer Res 1991;32:47.
11. Frucht H, Gazdar AF, Park JA, Oie H, Jensen RT. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 1992;52:1114-1122.
12. Radulovic S, Schally AV, Reile H, et al. Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice. Acta Oncol 1994;33:693-701.
13. Jensen JG, Carroll RE, Benya RV. The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer. Peptides 2001;22:689-699.
14. Ward JM. Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab Invest 1974;30:505-512.
15. Rogers AE, Nauss KM. Rodent models for carcinoma of the colon. Dig Dis Sci 1985;30:87S-102S.
16. Carroll RE, Matkowskyj KA, Tretiakova MS, Battey JF, Benya RV. Gastrin-releasing peptide is a mitogen and morphogen in murine colon cancer. Cell Growth Differ 2000;11:385-393.
17. Carroll RE, Carroll R, Benya RV. Characterization of gastrin-releasing peptide receptors aberrantly expressed by non-antral gastric adenocarcinomas. Peptides 1999;20:229-237.
18. Carroll RE, Ostrovskiy DA, Lee S, Danilkovich A, Benya RV. Characterization of gastrin-releasing peptide and its receptor aberrantly expressed by human colon cancer cell lines. Mol Pharmacol 2000;58:601-607.
19. Hamilton PW, Allen DC, Watt PC, Patterson CC, Biggart JD. Classification of normal colorectal mucosa and adenocarcinoma by morphometry. Histopathology 1989;11:901-911.
20. Fernandez-Lopez F, Paredes-Cotore JP, Cadarso-Suarez C, Forteza-Vila J, Puente-Dominguez JL, Potel-Lesquereux J. Prognostic value of nuclear morphometry in colorectal cancer. Dis Colon Rectum 1999;42:386-392.
21. Benya RV, Kusui T, Pradhan TK, Battey JF, Jensen RT. Expression and characterization of cloned human bombesin receptors. Mol Pharmacol 1995;47:10-20.
22. Benya RV, Wada E, Battey JF, et al. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: Analysis of binding, kinetics, stoichiometry, modulation by guanine proteins, signal transduction, and comparison with natively expressed receptors. Mol Pharmacol 1992;42:1058-1068.
23. Berridge MJ, Dawson RM, Downes CP, Helsop JP, Irvine RF. Changes in the levels of inositol phosphates after agnoist-dependent hydrolysis of membrane phosphoinositides. Biochem J 1983;212:473-482.
24. Wang LW, Mantey S, Lin JT, Frucht H, Jensen RT. Ligand binding, internalization, degradation and regulation by guanine nucleotides of bombesin receptor subtypes: A comparative study. Biochem Biophys Acta 1993;1175:232-242.
25. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science 1996;274:998-1001.
26. Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987;238:193-197.
27. Xiao D, Wang J, Hampton LL, Weber HC. The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter. Gene 2001;264:95-103.
28. Benya RV, Akeson M, Mrozinski JE, Jensen RT, Battey JF. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes. Mol Pharmacol 1994;46:495-501.
29. Ferris HA, Carroll RE, Rasenick MM, Benya RV. Constitutive activation of the gastrin-releasing peptide receptor expressed by the non-malignant human colon epithelial cell line NCM460. J Clin Invest 1997;100:2530-2537.
30. Rampaul RS, Pinder SE, Elston CW, Ellis IO. Prognostic and predictive factors in primary breast cancer and their role in patient management: The Nottingham Breast Team. Eur J Surg Oncol 2001;27:229-238.
31. Park YJ, Kim WH, Paeng SS, Park JG. Histoclinical analysis of early colorectal cancer. World J Surg 2000;24:1029-1035.
32. Mizejewski GJ. Role of integrins in cancer: Survey of expression patterns. Proc Soc Exp Biol Med 1999;222:124-138.
33. Riecken EO, Rosewicz S. Retinoids in pancreatic cancer. Ann Oncol 1999;10(Suppl 4):197-200.
34. Coindre JM. Histologic grading of adult soft tissue sarcomas. Verh Dtsch Ges Pathol 1998;82:59-63
35. Nicolson GL, Moustafa AS. Metastasis-associated genes and metastatic tumor progression. In Vivo 1998;12:579-588.
36. Ng IO. Prognostic significance of pathological and biological factors in hepatocellular carcinoma. J Gastroenterol Hepatol 1998;13:666-670.
37. Villavicencio H, Rubio-Briones J, Regalado R, Chechile G, Algaba F, Palou J. Grade, local stage and growth pattern as prognostic factors in carcinoma of the penis. Eur Urol 1997;32:442-447.
38. Birchmeier W, Behrens J, Weidner KM, Hulsken J, Birchmeier C. Epithelial differentiation and the control of metastasis in carcinomas. Curr Top Microbiol Immunol 1996;213:117-135.
39. Toi-Scott M, Jones CL, Kane MA. Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells. Lung Cancer 1996;15:341-354.
40. Gilbert SF. Developmental biology. 5 edn. Sunderland, MA: Sinauer Press; 1997.
41. Tahara E. Molecular mechanism of stomach carcinogenesis. Cancer Res Clin Oncol 1993;119:265-272.
42. Carroll RE, Matkowskyj KA, Saunthararajah Y, Sekosan M, Battey JF, Benya RV. Contribution of gastrin-releasing peptide and its receptor to villus development in the murine and human gastrointestinal tract. Mech Dev 2002;113:121-130.
43. Loeb LA. A mutator phenotype in cancer. Cancer Res 2001; 61:3230-3239.
44. Nowell PC. The clonal evolution of tumor populations. Science 1976;194:23-28.
45. Lotan R, Hong WL. Molecular mechanisms of chemoprevention and differentiation therapy. In: Mendelson J, Howley PM, Israel MA, Liotta LA, editors. The molecular basis of cancer. 2nd edn. Philadelphia, PA: W.B. Saunders; 2001. 621-648.